Download de presentatie
De presentatie wordt gedownload. Even geduld aub
GepubliceerdJoke Hendrickx Laatst gewijzigd meer dan 9 jaar geleden
1
Criteria for Invasive management Acute Coronary Syndromes (ACS) in patients presenting without persistent ST-segment elevation 20-4-20151Eduard van den Berg, cardio.nl
2
What is the target population Which is population of investigation of the the guideline ? So what is exactly the the title of the guideline ? 20-4-2015Eduard van den Berg, cardio.nl2
3
20-4-2015Eduard van den Berg, cardio.nl3
4
We look at the full tekst of the guideline 20-4-2015Eduard van den Berg, cardio.nl4
5
20-4-2015Eduard van den Berg, cardio.nl5
6
20-4-2015Eduard van den Berg, cardio.nl6
7
20-4-2015Eduard van den Berg, cardio.nl7
8
20-4-2015Eduard van den Berg, cardio.nl8
9
20-4-2015Eduard van den Berg, cardio.nl9
10
20-4-2015Eduard van den Berg, cardio.nl10
11
20-4-2015Eduard van den Berg, cardio.nl11
12
It is a working diagnosis The patient is assigned to a working diagnosis group Thereafter the proces of diagnosis validation starts 20-4-2015Eduard van den Berg, cardio.nl12
13
20-4-2015Eduard van den Berg, cardio.nl13
14
There is a low risk category This category also patient without CAD are included 20-4-2015Eduard van den Berg, cardio.nl14
15
20-4-2015Eduard van den Berg, cardio.nl15
16
20-4-2015Eduard van den Berg, cardio.nl16
17
And more in detail with Hs Trop With the working diagnosis NSTE-ACS there exists a probability of rapid ruling out ACS 20-4-2015Eduard van den Berg, cardio.nl17
18
20-4-2015Eduard van den Berg, cardio.nl18
19
Conclusion about the population The patients with the working diagnosis NSTE- ACS After the working diagnosis is made, the validation of the diagnosis starts Under this working diagnosis patients without ACS or even without CAD can be included 20-4-2015Eduard van den Berg, cardio.nl19
20
20-4-2015Eduard van den Berg, cardio.nl20
21
20-4-2015Eduard van den Berg, cardio.nl21
22
20-4-2015Eduard van den Berg, cardio.nl22
Verwante presentaties
© 2024 SlidePlayer.nl Inc.
All rights reserved.